Literature DB >> 17934083

Incidence and predictors of severe extra-articular disease manifestations in an early rheumatoid arthritis inception cohort.

C Turesson, K Eberhardt, L T H Jacobsson, E Lindqvist.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17934083      PMCID： PMC2111628          DOI： 10.1136/ard.2007.076521

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  10 in total

1.  No decrease over time in the incidence of vasculitis or other extraarticular manifestations in rheumatoid arthritis: results from a community-based study.

Authors:  Carl Turesson; Robyn L McClelland; Teresa J H Christianson; Eric L Matteson
Journal:  Arthritis Rheum       Date:  2004-11

2.  Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis.

Authors:  Carl Turesson; W Michael O'Fallon; Cynthia S Crowson; Sherine E Gabriel; Eric L Matteson
Journal:  J Rheumatol       Date:  2002-01       Impact factor: 4.666

3.  Ten year outcome in a cohort of patients with early rheumatoid arthritis: health status, disease process, and damage.

Authors:  E Lindqvist; T Saxne; P Geborek; K Eberhardt
Journal:  Ann Rheum Dis       Date:  2002-12       Impact factor: 19.103

4.  IgG rheumatoid factor, complement and immune complexes in rheumatoid synovitis and vasculitis: comparative and serial studies during cytotoxic therapy.

Authors:  D G Scott; P A Bacon; C Allen; C J Elson; T Wallington
Journal:  Clin Exp Immunol       Date:  1981-01       Impact factor: 4.330

5.  Decreases in rates of hospitalizations for manifestations of severe rheumatoid arthritis, 1983-2001.

Authors:  Michael M Ward
Journal:  Arthritis Rheum       Date:  2004-04

6.  Reference distributions for complement proteins C3 and C4: a practical, simple and clinically relevant approach in a large cohort.

Authors:  Robert F Ritchie; Glenn E Palomaki; Louis M Neveux; Olga Navolotskaia; Thomas B Ledue; Wendy Y Craig
Journal:  J Clin Lab Anal       Date:  2004       Impact factor: 2.352

7.  Anti-C1q affinity isolated circulating immune complexes correlate with extra-articular rheumatoid disease.

Authors:  R D Melsom; A C Horsfall; L Schrieber; P Charles; R N Maini
Journal:  Rheumatol Int       Date:  1986       Impact factor: 2.631

8.  Rheumatoid vasculitis: becoming extinct?

Authors:  R A Watts; J Mooney; S E Lane; D G I Scott
Journal:  Rheumatology (Oxford)       Date:  2004-05-04       Impact factor: 7.580

9.  Complement components in 100 newborns and their mothers determined by electroimmunoassay.

Authors:  U Johnson; L Truedsson; B Gustavii
Journal:  Acta Pathol Microbiol Immunol Scand C       Date:  1983-04

Review 10.  Epidemiology of extra-articular manifestations in rheumatoid arthritis.

Authors:  C Turesson; L T H Jacobsson
Journal:  Scand J Rheumatol       Date:  2004       Impact factor: 3.641
  10 in total
  11 in total

1.  The performance of the GAP model in patients with rheumatoid arthritis associated interstitial lung disease.

Authors:  Julie Morisset; Eric Vittinghoff; Bo Young Lee; Roberto Tonelli; Xiaowen Hu; Brett M Elicker; Jay H Ryu; Kirk D Jones; Stefania Cerri; Andreina Manfredi; Marco Sebastiani; Andrew J Gross; Brett Ley; Paul J Wolters; Talmadge E King; Dong Soon Kim; Harold R Collard; Joyce S Lee
Journal:  Respir Med       Date:  2017-04-22       Impact factor: 3.415

Review 2.  Methotrexate revisited: considerations for subcutaneous administration in RA.

Authors:  Randy Jay
Journal:  Clin Rheumatol       Date:  2014-11-30       Impact factor: 2.980

3.  Incidence of extraarticular rheumatoid arthritis in Olmsted County, Minnesota, in 1995-2007 versus 1985-1994: a population-based study.

Authors:  Elena Myasoedova; Cynthia S Crowson; Carl Turesson; Sherine E Gabriel; Eric L Matteson
Journal:  J Rheumatol       Date:  2011-04-01       Impact factor: 4.666

4.  Cutaneous manifestations are frequent and diverse among patients with rheumatoid arthritis and impact their quality of life: a cross-sectional study in a cohort of patients with recent-onset disease.

Authors:  Gabriela Sánchez-Cárdenas; Irazú Contreras-Yáñez; Guillermo Guaracha-Basáñez; Lexli D Pacheco-Santiago; Silvia Méndez-Flores; Ana Barrera-Vargas; Javier Merayo-Chalico; Judith Domínguez-Cherit; Virginia Pascual-Ramos
Journal:  Clin Rheumatol       Date:  2021-03-02       Impact factor: 2.980

5.  [Rituximab].

Authors:  E Feist; T Dörner
Journal:  Z Rheumatol       Date:  2010-09       Impact factor: 1.372

6.  [Personalized medicine for rheumatoid arthritis : serological and clinical patient profiles to optimize B and T cell targeted therapy].

Authors:  E Feist; T Dörner
Journal:  Z Rheumatol       Date:  2013-02       Impact factor: 1.372

7.  Cardiovascular disease is associated with extra-articular manifestations in patients with rheumatoid arthritis.

Authors:  Oscar-Danilo Ortega-Hernandez; Ricardo Pineda-Tamayo; Aryce L Pardo; Adriana Rojas-Villarraga; Juan-Manuel Anaya
Journal:  Clin Rheumatol       Date:  2009-03-10       Impact factor: 2.980

Review 8.  Prognostic factors in rheumatoid arthritis in the era of biologic agents.

Authors:  Alla Skapenko; Iryna Prots; Hendrik Schulze-Koops
Journal:  Nat Rev Rheumatol       Date:  2009-07-28       Impact factor: 20.543

9.  Incidence and complications of interstitial lung disease in users of tocilizumab, rituximab, abatacept and anti-tumor necrosis factor α agents, a retrospective cohort study.

Authors:  Jeffrey R Curtis; Khaled Sarsour; Pavel Napalkov; Laurie A Costa; Kathy L Schulman
Journal:  Arthritis Res Ther       Date:  2015-11-11       Impact factor: 5.156

10.  Foot orthoses for people with rheumatoid arthritis, involving quantitative and qualitative outcomes: protocol for a randomised controlled trial.

Authors:  Laura Ramos-Petersen; Christoper J Nester; Gabriel Gijon-Nogueron; Ana Belen Ortega-Avila
Journal:  BMJ Open       Date:  2020-07-19       Impact factor: 2.692
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.